This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN slid 3.08% to $2.52 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 3,845.08 and the Dow Jones Industrial Average DJIA rising 0.23% to 31,037.68. The stock's fall snapped a four-day winning streak. Ocugen Inc. closed $15.13 below its 52-week high ($17.65), which the company reached on November 3rd.
The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. ADVM rose 6.03% to $1.23, Ocular Therapeutix Inc. OCUL fell 1.38% to $4.28, and Kodiak Sciences Inc. KOD rose 1.49% to $8.15. Trading volume (5.2 M) remained 1.9 million below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 6, 2022.
(END) Dow Jones Newswires
July 06, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.